Author

Kirupananthan Seenithamby

Observed name: K Seenithamby

Institutions: Nottingham University Hospitals NHS Trust, Sri Ramachandra Institute of Higher Education and Research, University Hospitals of Leicester NHS Trust

Observed institutions: Mayo Clinic, Nottingham University Hospitals NHS Trust, Sri Ramachandra Institute of Higher Education and Research, University Hospitals of Leicester NHS Trust

OpenAlex ID: A5062899804

Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.

2013 · A Dispenzieri, K Seenithamby, et al. · Bone Marrow Transplantation · 83

A Thyrotoxic Periodic Paralysis Case Study: From Weakness to Wellness

2023 · Sharafath Hussain Zahir Hussain, Salam Al-Alousi, et al. · Cureus · 1

Patients with Immunoglobulin Light Chain Amyloidosis (AL) Undergoing High Dose Chemotherapy with Autologous Stem Cell Transplantation (ASCT) have Superior Outcomes As Compared to Patients with Multiple Myeloma (MM)

2012 · Kirupananthan Seenithamby, Angela Dispenzieri, et al. · Blood

Works count: 3

Citation count: 84

H-index: 1

I10-index: 1